Design and Synthesis of BCL6 BTB Inhibitor OICR12694

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2023; 19(04): 0409
DOI: 10.1055/s-0042-1752652

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Ferdinand H. Lutter (Janssen Pharmaceutica)

,

Danica A. Rankic (Pfizer)

non-Hodgkin lymphoma - BCL6 - protein–protein interaction - structure-based drug design

Article published online:
17 March 2023

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany